(311 days)
Anthogyr AXIOM® REG implants are intended for use as artificial root structures for replacement of missing teeth. They can be used for stabilization of removable prostheses or fixation of single tooth restorations or partial dentures. The Axiom dental system is indicated for one-stage or two-stage surgery.
It is up to the practitioner to decide whether immediate or delayed loading is most appropriate, based on clinical factors like good primary stability and appropriate occlusal loading.
Prefabricated components are intended for use as accessories to dental implants to support implant-supported restorations.
The AXIOM® REG Implant system has been designed in order to enhance the functional and aesthetic integration of implant supported restorations. The file concerns the expansion of prosthetic components and surgical instrumentation and also the implants of the AXIOM® REG.
Any abutment can be assembled on any AXIOM® REG implant thanks to its unique prosthetic connection, regardless of the implant diameter chosen.
-
Implants
Replacement of a missing root for placement of a dental restoration. The implant is screwed in the upper or lower jaw.
Material: Ti6Al4V
Surface treatment: BCP®
Dimensions: Ø3.4 mm, length: 16-18 mm
Ø 4.0 mm, length: 16-18 mm -
Conical abutments
Provide support for a permanent restoration, for multiple screw-retained prosthesis and screw-retained bar and brace
Material: Ti6Al4V
Dimensions: gingival height: 4.5 mm
angle: 18-30°
Rotational and non rotational abutments. -
Aesthetic titanium abutments
Provide support for a permanent restoration, single and multiple-unit cemented restoration.
Material: Ti6Al4V
Dimensions: Ø3.4 mm; gingival height: 2.5-4.5 mm; angle: 7-15°
Ø4.0 mm; gingival height: 0.75-4.5 mm; angle: 0-23°
Ø5.0 mm; gingival height: 0.75-4.5 mm; angle: 0-23°
Ø6.0 mm; gingival height: 1.5-4.5 mm; angle: 0-15°
Standard angulated titanium abutments
Provide support for a permanent restoration
Material: Ti6Al4V
Dimensions: Ø4.0 mm; gingival height: 1.5-3.5 mm; angle 15-23°
Ø5.0 mm; gingival height: 1.5-3.5 m; angle 15-23°
Temporary abutments
Provide support for a temporary restoration
Material: Ti6Al4V
Dimensions: Ø3.4 mm; height: 1.5-4.5 mm
Ø4.0 mm; height: 0.75-4.5 mm
Ø5.0 mm; height: 0.75-4.5 mm
Ø6.0 mm; height: 1.5-4.5 mm
Healing screws and healing screws flat
Sealing of implant conical connection during bone healing. Prepare gingiva to the permanent restoration shape.
Material: Ti6Al4V
Dimensions: Ø3.4 mm; height: 4.5 mm
Ø4.0 mm; height: 0.75-4.5 mm
Ø5.0 mm; height: 0.75-4.5 mm
Ø6.0 mm; height: 4.5 mm
Dimensions (flat version): Ø3.4 mm; height: 1.5-4.5 mm
Ø4.0 mm; height: 0.75-4.5 mm
Ø5.0 mm; height: 0.75-4.5 mm
Ø6.0 mm; height: 1.5-4.5 mm
Pacific system
Ensure passive fit between the conical abutment and the framework. Reserved exclusively for multiple or full-arch screw-retained prostheses on straight conical abutments.
Materials: Ti6Al4V, PMMA
Temporary cap and protecting cap
Give the negative shape of the permanent abutment for the design and realization by casting (lost wax process) of a dental restoration
Here's a breakdown of the acceptance criteria and study information for the AXIOM® REG device, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria Category | Specific Criteria (Implicitly based on predicate device comparison) | Reported Device Performance |
|---|---|---|
| Mechanical Properties | Comparable mechanical properties to predicate devices. | A fatigue testing according to the standard NF EN ISO 14801 (2007) has been performed for added devices. Results demonstrate comparable mechanical properties to the predicate device. |
| Material | Similar material as legally marketed predicate devices. | "substantially equivalent to its predicate devices in terms of intended use, material, design, mechanical properties and function." (Materials described as Ti6Al4V for implants and abutments, PMMA for Pacific system. These are standard in dental implants and implicitly comparable to predicates.) |
| Design | Similar design as legally marketed predicate devices. | "substantially equivalent to its predicate devices in terms of intended use, material, design, mechanical properties and function." |
| Function | Similar function as legally marketed predicate devices. | "substantially equivalent to its predicate devices in terms of intended use, material, design, mechanical properties and function." |
| Safety and Effectiveness | As safe and effective as predicate devices. | "Non clinical performance testing according to special control demonstrate that ANTHOGYR Endosseous dental implant system (AXIOM® REG) is as safe, effective, and performs as safely and effectively as its predicate devices." |
| Compliance | Conforms to Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments. | "AXIOM® Endosseous dental implant systems (AXIOM® REG) conforms to Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments - Guidance for Industry and FDA Staff Document issued on May 12, 2004." |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size for Test Set: Not specified in the provided text. The text only mentions "fatigue testing" according to a standard, but does not detail the number of units tested.
- Data Provenance: Not explicitly stated as prospective or retrospective. The testing was "performed for added devices," suggesting it was conducted specifically for this submission (likely prospective in the context of this regulatory filing). The country of origin for the testing is not mentioned, but the submitter is based in France.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications
This information is not applicable and not provided in the document. The study described is a non-clinical, mechanical fatigue test, not a clinical study involving human expert assessment or ground truth establishment based on clinical observations.
4. Adjudication Method for the Test Set
This information is not applicable and not provided. As noted above, this was a mechanical test, not a study requiring adjudication of clinical data.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size of AI vs. Without AI Assistance
This information is not applicable and not provided. This device is a dental implant system (hardware), not an AI-powered diagnostic or assistive tool. Therefore, an MRMC study comparing human readers with and without AI assistance is irrelevant to this submission.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
This information is not applicable and not provided. This device is a physical dental implant system and prefabricated components, not an algorithm or software.
7. The Type of Ground Truth Used
The "ground truth" for the mechanical performance testing was the established pass/fail criteria and performance characteristics defined by the NF EN ISO 14801 (2007) standard for fatigue testing of endosseous dental implants, against which the predicate devices presumably also complied. The objective was to demonstrate "comparable mechanical properties" to the predicate.
8. The Sample Size for the Training Set
This information is not applicable and not provided. There is no "training set" as this is a physical medical device undergoing mechanical validation, not a machine learning model.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable and not provided. As above, there is no training set for this type of device.
{0}------------------------------------------------
FEB 2 1 2014
.
510(k) SUMMARY
| ANTHOGYR SAS | |
|---|---|
| Submitter | 2237, avenue Andre LasquinSALLANCHES, FRANCE 74700Registration Number: 8020776 |
| Contacts | Ms Thérèse CANDAU m,candau@anthogyr.comPhone (33) (0)4 50 58 02 37 Fax (33) (0)4 50 93 78 60Regulatory: Dr Isabelle DRUBAIX (PhD) IDEE CONSULTINGidrubaix@nordnet.fr |
| Trade Name | AXIOM® REG |
| Classification | ENDOSSEOUS DENTAL IMPLANT |
| Name | ENDOSSEOUS DENTAL ABUTMENT |
| Class | II |
| Product Code | DZENHA |
| CFR section | 21CFR 872.3640 |
| Device panel | DENTAL |
| Legally marketedpredicate devices | AXIOM dental Implant system K101913Nobel Speedy Replace K050406Dentsply Friadent implant system - XIVE S Plus K073075Dentsply Ankylos C/X K083805 |
| Description | The AXIOM® REG Implant system has been designed in order to enhancethe functional and aesthetic integration of implant supported restorations..The file concerns the expansion of prosthetic components and surgicalinstrumentation and also the implants of the AXIOM® REG.Any abutment can be assembled on any AXIOM® REG implant thanks to itsunique prosthetic connection, regardless of the implant diameter chosen.- ImplantsReplacement of a missing root for placement of a dental restoration. Theimplant is screwed in the upper or lower jaw.Material: Ti6Al4VSurface treatment: BCP®Dimensions: Ø3.4 mm, length: 16-18 mmØ 4.0 mm, length: 16-18 mm- Conical abutmentsProvide support for a permanent restoration, for multiple screw-retainedprosthesis and screw-retained bar and braceMaterial: Ti6Al4VDimensions: gingival height: 4.5 mmangle: 18-30°Rotational and non rotational abutments.- Aesthetic titanium abutmentsProvide support for a permanent restoration, single and multiple-unitcemented restoration.Material: Ti6Al4VDimensions: Ø3.4 mm; gingival height: 2.5-4.5 mm; angle: 7-15° |
| Ø4.0 mm; gingival height: 0.75-4.5 mm; angle: 0-23° | |
| Ø5.0 mm; gingival height: 0.75-4.5 mm; angle: 0-23° | |
| Ø6.0 mm; gingival height: 1.5-4.5 mm; angle: 0-15° | |
| Standard angulated titanium abutments | |
| Provide support for a permanent restoration | |
| Material: Ti6Al4V | |
| Dimensions: Ø4.0 mm; gingival height: 1.5-3.5 mm; angle 15-23° | |
| Ø5.0 mm; gingival height: 1.5-3.5 m; angle 15-23° | |
| Temporary abutments | |
| Provide support for a temporary restoration | |
| Material: Ti6Al4V | |
| Dimensions: Ø3.4 mm; height: 1.5-4.5 mm | |
| Ø4.0 mm; height: 0.75-4.5 mm | |
| Ø5.0 mm; height: 0.75-4.5 mm | |
| Ø6.0 mm; height: 1.5-4.5 mm | |
| Healing screws and healing screws flatSealing of implant conical connection during bone healing. Prepare gingiva to the permanent restoration shape. | |
| Material: Ti6Al4V | |
| Dimensions: Ø3.4 mm; height: 4.5 mm | |
| Ø4.0 mm; height: 0.75-4.5 mm | |
| Ø5.0 mm; height: 0.75-4.5 mm | |
| Ø6.0 mm; height: 4.5 mm | |
| Dimensions (flat version): Ø3.4 mm; height: 1.5-4.5 mm | |
| Ø4.0 mm; height: 0.75-4.5 mm | |
| Ø5.0 mm; height: 0.75-4.5 mm | |
| Ø6.0 mm; height: 1.5-4.5 mm | |
| Pacific system | |
| Ensure passive fit between the conical abutment and the framework.Reserved exclusively for multiple or full-arch screw-retained prostheses on straight conical abutments. | |
| Materials: Ti6Al4V, PMMA | |
| Temporary cap and protecting capGive the negative shape of the permanent abutment for the design and realization by casting (lost wax process) of a dental restoration | |
| Anthogyr AXIOM® REG implants are intended for use as artificial root structures for replacement of missing teeth. They can be used for stabilization of removable prostheses or fixation of single tooth restorations or partial dentures.The Axiom dental system is indicated for one-stage or two-stage surgery. | |
| Indications for use | It is up to the practitioner to decide whether immediate or delayed loading is most appropriate, based on clinical factors like good primary stability and appropriate occlusal loading.Prefabricated components are intended for use as accessories to dental implants to support implant-supported restorations. |
Section 5 - page 2 / 4
:
{1}------------------------------------------------
Section 5 - page 3 / 4
:
and the same of the same
.
{2}------------------------------------------------
| Performance data | AXIOM® Endosseous dental implant systems (AXIOM® REG) conforms toClass II Special Controls Guidance Document: Root-form Endosseous DentalImplants and Endosseous Dental Abutments - Guidance for Industry andFDA Staff Document issued on May 12, 2004.A fatigue testing according to the standard NF EN ISO 14801 (2007) hasbeen performed for added devices.Results demonstrate comparable mechanical properties to the predicatedevice. No clinical data has been presented. | |
|---|---|---|
| Substantialequivalence | ANTHOGYR Endosseous dental implant systems (AXIOM® REG) issubstantially equivalent to its predicate devices in terms of intended use,material, design, mechanical properties and function. Non clinicalperformance testing according to special control demonstrate thatANTHOGYR Endosseous dental implant system (AXIOM® REG) is as safe,effective, and performs as safely and effectively as its predicate devices. | |
| Preparation date | February 19th 2014 |
:
:
.
.
.
.
{3}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is a stylized symbol that resembles an eagle or bird in flight, with three curved lines representing its wings.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 21, 2014
Ms. Therese Candau Regulatory Affairs Engineer Anthogyr SAS 2237 Avenue Andre Lasquin Sallanches, FRANCE 74700
Re: K131066
Trade/Device Name: Axiom REG Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE, NHA Dated: January 15, 2014 Received: January 22, 2014
Dear Ms. Candau:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
Page 2 - Mr. Candau
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that vour device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers. International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Image /page/4/Picture/7 description: The image shows the name Kwame Ulmer-S in a stylized font. The letters are bold and black, and they appear to be slightly distorted. The background of the image is a pattern of small squares and lines. The overall effect is modern and abstract.
for
Erin 1. Keith, M.S. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
| DEPARTMENT OF HEALTH AND HUMAN SERVICES |
|---|
| Food and Drug Administration |
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement befoly.
510(k) Number (if known) KIJ 1066
Device Name AXION REG
Indications for Use (Describe)
Anthogyr AXIOM® REG implants are intended for use as artificial root structures for replacement of missing teeth. They can be used for stabilization of removable prostheses or fixation of single tooth restorations or partial dentures. The Axiom dental system is indicated for one-stage or two-stage surgery.
It is up to the practitioner to decide whether immediate or delayed loading is most appropriate, based on clinical factors like good primary stability and appropriate occlusal loading.
Prefabricated components are intended for use as accessories to dental implants to support implant-supported restorations.
Type of Use (Selact one or both, as applicable)
2 Prescription Use {Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
| Concurrence of Center for Devices and Radiological Health (CDRH) (Signature) | Mary S. Runner -SSusan Runner DDS, MA 2014.02.2109:42:24′-05'00' |
|---|---|
| ------------------------------------------------------------------------------ | -------------------------------------------------------------------------- |
This section applies only to requirements of the Paperwork Reduction Act of 1995.
"DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."
FORM FDA 38B1 (1/14)
Page 1 of 1
PSC Friederland Services (101) 443-6745 EF
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.